PERFU+3 Partnership
PERFU+3 is a CIR-V40 mechanical platform delivering 110–130 mbar without external power.
It is positioned for licensing or transfer discussions with organizations active in infusion, emergency care, and medical transport.
A platform prepared for industrial dialogue
PERFU+3 is presented as a defined mechanical platform, built on a stabilized baseline (CIR-V40), and structured to support transfer-oriented industrial engagement.
Fully mechanical architecture
Battery-free operating logic for constrained environments.
Controlled service range
110–130 mbar operating envelope.
Compact deployment format
Prepared for field-oriented partner review.
Documented baseline
Transfer-oriented technical asset for qualified discussions.
Division of responsibilities
AXELYUM MEDTECH provides
- Complete platform architecture
- IP package + CIR-V40 baseline
- Transfer-oriented technical documentation
- Structured engagement framework
The partner completes
- Industrialization
- Regulatory execution
- Series manufacturing
- Market integration
Objective: enable a seamless transition into your industrial capabilities. PERFU+3 is delivered as a structured platform; you bring it to scale.
Why this platform
PERFU+3 addresses environments in which dependence on gravity, electrical continuity, or complex infrastructure becomes a limitation.
Its approach is deliberately different: no batteries, no electronics, no software dependency, and a gravity-independent operating logic.
Engagement logic
Initial material is shared selectively, based on counterpart profile and discussion relevance.
Initial review begins with an Executive Summary. Further technical information may be shared progressively, depending on counterpart profile and discussion maturity. Where appropriate, access is provided under NDA.
Discreet answers to essential questions
A long development path
PERFU+3 is the industrial maturation of a long mechanical infusion development path. Earlier generations validated the operational relevance of autonomous mechanical infusion; the current platform is structured for transfer-oriented industrial engagement.
Current status
PERFU+3 is not presented as a commercialized end product. It is a defined mechanical platform (CIR-V40 baseline) intended to support industrialization, regulatory execution, and partner-led deployment.
Information access
Initial material is provided through an Executive Summary. Further technical information is shared progressively, depending on counterpart profile and discussion maturity.
How discussions begin
A first-level review of the platform, its positioning, and its transfer logic.
Assessment of counterpart profile, strategic relevance, and possible fit.
Clarification of intended territory, use case, and discussion scope.
Access to more sensitive material under controlled conditions.
Selective by design
PERFU+3 is presented through a disciplined access logic. This site is intended for first-level qualified review. Further material is shared selectively.